首页 > 最新文献

中国修复重建外科杂志最新文献

英文 中文
[A study of burden of gout disease in adults attributable to high body mass index and impaired kidney function in China from 1990 to 2023]. [1990 - 2023年中国成人高体重指数和肾功能受损所致痛风疾病负担研究]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601049
Qingsong Liu, Lin Hu, Yunan Hu, Qianjiang Xiong, Jian Li, Chunxia Yang, Weili Fu

Objective: To analyze the changing trends in the burden of gout disease attributable to high body mass index (BMI) and impaired kidney function in China from 1990 to 2023, and predict the burden of gout disease attributable to high BMI and impaired kidney function in China from 2024 to 2035, to provide a scientific basis for gout prevention and control.

Methods: Based on the 2023 Global Burden of Disease (GBD) study data, this study analysed the characteristics of the burden of gout attributable to high BMI and impaired kidney function by gender and age group. It employed the Joinpoint regression model to examine trends in the age-standardized disability-adjusted life years (DALYs) rate and utilized the autoregressive integrated moving average (ARIMA) model to predict the disease burden trend from 2024 to 2035.

Results: From 1990 to 2023, the age-standardized DALYs rate for gout attributable to high BMI in China increased (1990: 3.79 per 100 000, 95% UI: 2.15 per 100 000-6.24 per 100 000; 2023: 7.34 per 100 000, 95% UI: 4.22 per 100 000-11.39 per 100 000). Joinpoint analysis results showed that from 1990 to 2023, the age-standardized DALYs rate for gout attributable to high BMI in China exhibited an overall upward trend [average annual percent change (AAPC) for males=2.12%, 95% CI: 2.02%-2.22%; AAPC for females=1.92%, 95% CI: 1.79%-2.04%, both P<0.05]. For gout attributable to impaired kidney function, the age-standardized DALYs rate showed a slow overall increase in males, while the change in females was not significant (AAPC for males=0.36%, 95% CI: 0.27%-0.45%, P<0.05; AAPC for females=0.11%, 95% CI: -0.11%-0.33%). According to the ARIMA model predictions, by 2035, the age-standardized DALYs rates of gout attributable to high BMI in males and females and attributable to impaired kidney function in females were projected to stabilize at 10.85 per 100 000, 3.48 per 100 000, and 1.75 per 100 000, respectively. In contrast, the age-standardized DALYs rate of gout attributable to impaired kidney function in males was predicted to continue rising until 2035, reaching an estimated 5.98 per 100 000.

Conclusion: The disease burden of gout associated with high BMI and impaired kidney function continues to worsen in China. The age-standardized DALYs rate for gout attributable to impaired kidney function in males is projected to continue rising until 2035. Therefore, there is an urgent need to improve population-wide BMI management strategies and enhance medical support for patients with kidney diseases, with targeted interventions prioritized among specific groups such as middle-aged obese individuals and middle-aged and elderly patients with kidney diseases.

目的:分析1990 - 2023年中国高体重指数(BMI)和肾功能受损所致痛风疾病负担变化趋势,预测2024 - 2035年中国高体重指数(BMI)和肾功能受损所致痛风疾病负担,为痛风防控提供科学依据。方法:基于2023年全球疾病负担(GBD)研究数据,按性别和年龄组分析高BMI和肾功能受损导致的痛风负担特征。采用Joinpoint回归模型考察了年龄标准化失能调整生命年(DALYs)率的变化趋势,并利用自回归综合移动平均(ARIMA)模型预测了2024 - 2035年疾病负担的变化趋势。结果:1990 - 2023年,中国高BMI导致的痛风年龄标准化DALYs率上升(1990年:3.79 / 10万,95% UI: 2.15 / 10万~ 6.24 / 10万;2023年:7.34 / 10万,95% UI: 4.22 / 10万~ 11.39 / 10万)。结合点分析结果显示,1990 - 2023年,中国因高BMI导致的痛风年龄标准化DALYs率总体呈上升趋势[男性平均年百分比变化(AAPC) =2.12%, 95% CI: 2.02%-2.22%;AAPC女性= 1.92%,95%置信区间CI: 1.79% - -2.04%,这两个PCI: PCI: -0.11% - -0.33%, 0.27% - -0.45%)。根据ARIMA模型预测,到2035年,男性和女性归因于高BMI和女性归因于肾功能受损的痛风年龄标准化DALYs率预计分别稳定在10.85 / 10万,3.48 / 10万和1.75 / 10万。相比之下,男性因肾功能受损导致的痛风年龄标准化DALYs率预计将继续上升至2035年,估计达到5.98 / 10万。结论:在中国,与高BMI和肾功能受损相关的痛风疾病负担持续加重。预计到2035年,男性因肾功能受损导致的痛风年龄标准化DALYs比率将继续上升。因此,迫切需要完善全人群BMI管理策略,加强对肾脏疾病患者的医疗支持,并优先针对特定人群,如中年肥胖者和中老年肾脏疾病患者进行有针对性的干预。
{"title":"[A study of burden of gout disease in adults attributable to high body mass index and impaired kidney function in China from 1990 to 2023].","authors":"Qingsong Liu, Lin Hu, Yunan Hu, Qianjiang Xiong, Jian Li, Chunxia Yang, Weili Fu","doi":"10.7507/1002-1892.202601049","DOIUrl":"10.7507/1002-1892.202601049","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the changing trends in the burden of gout disease attributable to high body mass index (BMI) and impaired kidney function in China from 1990 to 2023, and predict the burden of gout disease attributable to high BMI and impaired kidney function in China from 2024 to 2035, to provide a scientific basis for gout prevention and control.</p><p><strong>Methods: </strong>Based on the 2023 Global Burden of Disease (GBD) study data, this study analysed the characteristics of the burden of gout attributable to high BMI and impaired kidney function by gender and age group. It employed the Joinpoint regression model to examine trends in the age-standardized disability-adjusted life years (DALYs) rate and utilized the autoregressive integrated moving average (ARIMA) model to predict the disease burden trend from 2024 to 2035.</p><p><strong>Results: </strong>From 1990 to 2023, the age-standardized DALYs rate for gout attributable to high BMI in China increased (1990: 3.79 per 100 000, 95% <i>UI</i>: 2.15 per 100 000-6.24 per 100 000; 2023: 7.34 per 100 000, 95% <i>UI</i>: 4.22 per 100 000-11.39 per 100 000). Joinpoint analysis results showed that from 1990 to 2023, the age-standardized DALYs rate for gout attributable to high BMI in China exhibited an overall upward trend [average annual percent change (AAPC) for males=2.12%, 95% <i>CI</i>: 2.02%-2.22%; AAPC for females=1.92%, 95% <i>CI</i>: 1.79%-2.04%, both <i>P</i><0.05]. For gout attributable to impaired kidney function, the age-standardized DALYs rate showed a slow overall increase in males, while the change in females was not significant (AAPC for males=0.36%, 95% <i>CI</i>: 0.27%-0.45%, <i>P</i><0.05; AAPC for females=0.11%, 95% <i>CI</i>: -0.11%-0.33%). According to the ARIMA model predictions, by 2035, the age-standardized DALYs rates of gout attributable to high BMI in males and females and attributable to impaired kidney function in females were projected to stabilize at 10.85 per 100 000, 3.48 per 100 000, and 1.75 per 100 000, respectively. In contrast, the age-standardized DALYs rate of gout attributable to impaired kidney function in males was predicted to continue rising until 2035, reaching an estimated 5.98 per 100 000.</p><p><strong>Conclusion: </strong>The disease burden of gout associated with high BMI and impaired kidney function continues to worsen in China. The age-standardized DALYs rate for gout attributable to impaired kidney function in males is projected to continue rising until 2035. Therefore, there is an urgent need to improve population-wide BMI management strategies and enhance medical support for patients with kidney diseases, with targeted interventions prioritized among specific groups such as middle-aged obese individuals and middle-aged and elderly patients with kidney diseases.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"430-437"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rehabilitation guidelines and specifications for traumatic spinal cord injury (2025 edition)]. [创伤性脊髓损伤康复指南和规范(2025年版)]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601061
Professional Committee Of Spine And Spinal Cord Injury Rehabilitation China Association Of Rehabilitation Of Disabled Persons, Professional Committee Of Spine Chinese Association Of Rehabilitation Medicine, The Second Medical-Rehabilitation Integration Working Committee Chinese Association Of Rehabilitation Medicine, Spine And Spinal Cord Injury Repair Study Group The Third Professional Committee Of Neurorestoratology Chinese Medical Doctor Association

Objective: To address the lack of unified group standards, inconsistent rehabilitation service processes, and waste of rehabilitation resources in the field of traumatic spinal cord injury (TSCI) rehabilitation in China, a standardized rehabilitation specifications for TSCI was established based on the 2017 expert consensus, the latest evidence-based medical evidence, and the International Classification of Functioning, Disability and Health (ICF) framework.

Methods: Led by the China Rehabilitation Research Center and funded by the National Key Research and Development Program of China and the Capital Health Research and Development of Special Funds, this guideline was developed by experts from multiple renowned domestic institutions, drawing on international experience and combining it with clinical practice in China.

Results: Rehabilitation Guidelines and Specifications for Traumatic Spinal Cord Injury (2025 Edition) clarifies the terminology and definitions of TSCI and specifies standards for the entire process, including pre-hospital first aid, emergency management, clinical diagnosis, acute phase clinical treatment, rehabilitation assessment, and rehabilitation therapy. It details rehabilitation protocols such as physical therapy (motor therapy), occupational therapy, vocational rehabilitation, social rehabilitation, and psychological rehabilitation. Furthermore, it provides specific rehabilitation management strategies for common complications involving the respiratory system, bowel, bladder, cardiovascular system, as well as pain, spasticity, and pressure injuries.

Conclusion: This guideline is applicable to medical and health institutions at all levels involved in the diagnosis and treatment of TSCI. Early, accurate, and standardized rehabilitation treatment can effectively reduce disability rates, restore limb function, and improve patients' quality of life. The formulation of this guideline provides a significant basis for the standardized treatment and rehabilitation of TSCI patients in China.

目的:针对中国创伤性脊髓损伤(TSCI)康复领域缺乏统一的团体标准、康复服务流程不一致、康复资源浪费等问题,基于2017年专家共识、最新循证医学证据和国际功能、残疾与健康分类(ICF)框架,制定TSCI标准化康复规范。方法:本指南由中国康复研究中心牵头,在国家重点研发计划和首都卫生研发专项资金的支持下,由国内多家知名机构专家借鉴国际经验,结合国内临床实践共同制定。结果:《创伤性脊髓损伤康复指南与规范(2025版)》明确了创伤性脊髓损伤的术语和定义,规定了院前急救、应急管理、临床诊断、急性期临床治疗、康复评估、康复治疗等全流程标准。它详细介绍了康复方案,如物理治疗(运动治疗)、职业治疗、职业康复、社会康复和心理康复。此外,它还为呼吸系统、肠、膀胱、心血管系统以及疼痛、痉挛和压力损伤等常见并发症提供了具体的康复管理策略。结论:本指南适用于参与TSCI诊治的各级医疗卫生机构。早期、准确、规范的康复治疗可有效降低致残率,恢复肢体功能,提高患者的生活质量。该指南的制定为中国TSCI患者的规范化治疗和康复提供了重要依据。
{"title":"[Rehabilitation guidelines and specifications for traumatic spinal cord injury (2025 edition)].","authors":"Professional Committee Of Spine And Spinal Cord Injury Rehabilitation China Association Of Rehabilitation Of Disabled Persons, Professional Committee Of Spine Chinese Association Of Rehabilitation Medicine, The Second Medical-Rehabilitation Integration Working Committee Chinese Association Of Rehabilitation Medicine, Spine And Spinal Cord Injury Repair Study Group The Third Professional Committee Of Neurorestoratology Chinese Medical Doctor Association","doi":"10.7507/1002-1892.202601061","DOIUrl":"10.7507/1002-1892.202601061","url":null,"abstract":"<p><strong>Objective: </strong>To address the lack of unified group standards, inconsistent rehabilitation service processes, and waste of rehabilitation resources in the field of traumatic spinal cord injury (TSCI) rehabilitation in China, a standardized rehabilitation specifications for TSCI was established based on the 2017 expert consensus, the latest evidence-based medical evidence, and the International Classification of Functioning, Disability and Health (ICF) framework.</p><p><strong>Methods: </strong>Led by the China Rehabilitation Research Center and funded by the National Key Research and Development Program of China and the Capital Health Research and Development of Special Funds, this guideline was developed by experts from multiple renowned domestic institutions, drawing on international experience and combining it with clinical practice in China.</p><p><strong>Results: </strong>Rehabilitation Guidelines and Specifications for Traumatic Spinal Cord Injury (2025 Edition) clarifies the terminology and definitions of TSCI and specifies standards for the entire process, including pre-hospital first aid, emergency management, clinical diagnosis, acute phase clinical treatment, rehabilitation assessment, and rehabilitation therapy. It details rehabilitation protocols such as physical therapy (motor therapy), occupational therapy, vocational rehabilitation, social rehabilitation, and psychological rehabilitation. Furthermore, it provides specific rehabilitation management strategies for common complications involving the respiratory system, bowel, bladder, cardiovascular system, as well as pain, spasticity, and pressure injuries.</p><p><strong>Conclusion: </strong>This guideline is applicable to medical and health institutions at all levels involved in the diagnosis and treatment of TSCI. Early, accurate, and standardized rehabilitation treatment can effectively reduce disability rates, restore limb function, and improve patients' quality of life. The formulation of this guideline provides a significant basis for the standardized treatment and rehabilitation of TSCI patients in China.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"343-357"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research advances on subchondral insufficiency fracture and osteonecrosis of the knee]. 膝关节软骨下不全性骨折及骨坏死的研究进展。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202510036
Zhenwei Zou, Yirong Zeng, Jianchun Zeng

Objective: To clarify the clinical application of the disease terms "subchondral insufficiency fracture of the knee (SIFK)" and "osteonecrosis of the knee (ONK)", and to review the research progress on this pathological condition.

Methods: The research literature in the field of SIFK and ONK both domestically and internationally in recent years was widely reviewed, and the research progress of SIFK and ONK was summarized from the aspects of the current conceptual frameworks, etiological factors and pathogenic mechanisms, clinical and imaging manifestations, therapeutic approaches, and prognostic outcomes.

Results: The exact etiology of SIFK remains controversial, and its specific pathogenesis has not been fully elucidated. Subchondral fracture has been identified as the primary pathological feature of this disease entity. SIFK predominantly affects the females over 65 years old, presenting with sudden onset of severe and persistent pain. MRI serves as the gold standard for diagnosis of early-stage SIFK. The characteristic MRI findings include bone marrow edema-like signals and a subchondral low-signal line in the affected femoral condyle. Generally, if bone morphology is preserved without subchondral bone collapse, conservative management is typically the first-line treatment approach. Surgical intervention should be considered if there is no clinical or radiographic improvement after 3 to 4 months of conservative therapy.

Conclusion: Considering the pathological features of bone specimens, adopting the SIFK for ONK demonstrates greater appropriateness in diagnosis and management of these disorders. Early diagnosis and management are important for improving the prognosis of SIFK patients.

目的:阐明“膝关节软骨下不全性骨折(SIFK)”和“膝关节骨坏死(ONK)”这两个疾病术语的临床应用,并对这一病理状况的研究进展进行综述。方法:广泛查阅近年来国内外在SIFK和ONK领域的研究文献,从目前的概念框架、病因及致病机制、临床及影像学表现、治疗途径、预后结局等方面总结SIFK和ONK的研究进展。结果:SIFK的确切病因仍有争议,其具体的发病机制尚未完全阐明。软骨下骨折已被确定为该疾病的主要病理特征。SIFK主要影响65岁以上的女性,表现为突然发作的严重和持续的疼痛。MRI是早期SIFK诊断的金标准。特征性MRI表现包括骨髓水肿样信号和受累股骨髁软骨下低信号线。一般来说,如果骨形态得以保存而没有软骨下骨塌陷,保守治疗通常是一线治疗方法。如果保守治疗3 - 4个月后临床或影像学无改善,应考虑手术干预。结论:考虑到骨标本的病理特点,采用SIFK进行ONK诊断和治疗具有更高的适用性。早期诊断和治疗对于改善SIFK患者的预后至关重要。
{"title":"[Research advances on subchondral insufficiency fracture and osteonecrosis of the knee].","authors":"Zhenwei Zou, Yirong Zeng, Jianchun Zeng","doi":"10.7507/1002-1892.202510036","DOIUrl":"10.7507/1002-1892.202510036","url":null,"abstract":"<p><strong>Objective: </strong>To clarify the clinical application of the disease terms \"subchondral insufficiency fracture of the knee (SIFK)\" and \"osteonecrosis of the knee (ONK)\", and to review the research progress on this pathological condition.</p><p><strong>Methods: </strong>The research literature in the field of SIFK and ONK both domestically and internationally in recent years was widely reviewed, and the research progress of SIFK and ONK was summarized from the aspects of the current conceptual frameworks, etiological factors and pathogenic mechanisms, clinical and imaging manifestations, therapeutic approaches, and prognostic outcomes.</p><p><strong>Results: </strong>The exact etiology of SIFK remains controversial, and its specific pathogenesis has not been fully elucidated. Subchondral fracture has been identified as the primary pathological feature of this disease entity. SIFK predominantly affects the females over 65 years old, presenting with sudden onset of severe and persistent pain. MRI serves as the gold standard for diagnosis of early-stage SIFK. The characteristic MRI findings include bone marrow edema-like signals and a subchondral low-signal line in the affected femoral condyle. Generally, if bone morphology is preserved without subchondral bone collapse, conservative management is typically the first-line treatment approach. Surgical intervention should be considered if there is no clinical or radiographic improvement after 3 to 4 months of conservative therapy.</p><p><strong>Conclusion: </strong>Considering the pathological features of bone specimens, adopting the SIFK for ONK demonstrates greater appropriateness in diagnosis and management of these disorders. Early diagnosis and management are important for improving the prognosis of SIFK patients.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"482-486"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress of tibial tunnel positioning techniques in posterior cruciate ligament reconstruction]. 后交叉韧带重建中胫骨隧道定位技术的研究进展。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202510050
Runze Li, Yatong Liao, Fengyuan Guo, Qianzeng Chen, Song Li, Chuan He

Objective: To review the research on tibial tunnel positioning techniques in posterior cruciate ligament (PCL) reconstruction to provide references for clinical practice.

Methods: Relevant literature on tibial tunnel positioning techniques in PCL reconstruction was extensively reviewed, and summarized. Their advantages, disadvantages, and clinical outcomes were compared.

Results: The position of the tibial tunnel is crucial to the prognosis of PCL reconstruction. The commonly used tibial tunnel positioning techniques include transtibial anteromedial anatomical reconstruction, transtibial anterolateral anatomical reconstruction, Inlay technique, and modified tibial low tunnel reconstruction. Recent studies have shown that there is no significant difference in clinical function scores between anterolateral and anteromedial reconstructions, but the former is associated with greater postoperative posterior tibial translation, which may lead to poor knee joint stability in the long-term follow-up. Compared with other techniques, the Inlay technique is more invasive and is generally not the first clinical choice. In contrast to anteromedial reconstruction, modified tibial low tunnel reconstruction can reduce graft wear. But, studies have demonstrated no significant difference in clinical outcomes between the two techniques. In addition, the modified tibial low tunnel reconstruction is a non-anatomical reconstruction method. Studies have indicated that the degree of posterior tibial translation after non-anatomical reconstructions is greater than that after anatomical reconstruction. Whether the knee joint stability can be guaranteed after non-anatomical reconstruction remains unclear, so the advantages of this technique need to be further investigated.

Conclusion: Different tibial positioning techniques have their own merits and demerits. At present, there is no clear evidence that any technique has absolute advantages. Surgeons should make a choice based on their own specific conditions and the patient's specific situation.

目的:综述后交叉韧带重建中胫骨隧道定位技术的研究进展,为临床提供参考。方法:广泛查阅有关胫骨隧道定位技术在PCL重建中的相关文献,并进行总结。比较两种方法的优缺点及临床结果。结果:胫骨隧道的位置对胫韧带重建的预后至关重要。常用的胫骨隧道定位技术包括经胫骨前内侧解剖重建术、经胫骨前外侧解剖重建术、Inlay技术、改良胫骨低位隧道重建术等。近期研究表明,前外侧重建与前内侧重建的临床功能评分无显著差异,但前者术后胫骨后移位较大,长期随访可能导致膝关节稳定性差。与其他技术相比,嵌体技术更具侵入性,通常不是临床的首选。与前内侧重建相比,改良的胫骨低隧道重建可以减少移植物的磨损。但是,研究表明两种技术在临床结果上没有显著差异。改良胫骨下隧道重建是一种非解剖性重建方法。研究表明,非解剖重建后胫骨后移位程度大于解剖重建后。非解剖重建后能否保证膝关节的稳定性尚不清楚,因此该技术的优势有待进一步研究。结论:不同的胫骨定位技术各有优缺点。目前,还没有明确的证据表明任何一种技术具有绝对的优势。外科医生应根据自身的具体情况和患者的具体情况进行选择。
{"title":"[Research progress of tibial tunnel positioning techniques in posterior cruciate ligament reconstruction].","authors":"Runze Li, Yatong Liao, Fengyuan Guo, Qianzeng Chen, Song Li, Chuan He","doi":"10.7507/1002-1892.202510050","DOIUrl":"10.7507/1002-1892.202510050","url":null,"abstract":"<p><strong>Objective: </strong>To review the research on tibial tunnel positioning techniques in posterior cruciate ligament (PCL) reconstruction to provide references for clinical practice.</p><p><strong>Methods: </strong>Relevant literature on tibial tunnel positioning techniques in PCL reconstruction was extensively reviewed, and summarized. Their advantages, disadvantages, and clinical outcomes were compared.</p><p><strong>Results: </strong>The position of the tibial tunnel is crucial to the prognosis of PCL reconstruction. The commonly used tibial tunnel positioning techniques include transtibial anteromedial anatomical reconstruction, transtibial anterolateral anatomical reconstruction, Inlay technique, and modified tibial low tunnel reconstruction. Recent studies have shown that there is no significant difference in clinical function scores between anterolateral and anteromedial reconstructions, but the former is associated with greater postoperative posterior tibial translation, which may lead to poor knee joint stability in the long-term follow-up. Compared with other techniques, the Inlay technique is more invasive and is generally not the first clinical choice. In contrast to anteromedial reconstruction, modified tibial low tunnel reconstruction can reduce graft wear. But, studies have demonstrated no significant difference in clinical outcomes between the two techniques. In addition, the modified tibial low tunnel reconstruction is a non-anatomical reconstruction method. Studies have indicated that the degree of posterior tibial translation after non-anatomical reconstructions is greater than that after anatomical reconstruction. Whether the knee joint stability can be guaranteed after non-anatomical reconstruction remains unclear, so the advantages of this technique need to be further investigated.</p><p><strong>Conclusion: </strong>Different tibial positioning techniques have their own merits and demerits. At present, there is no clear evidence that any technique has absolute advantages. Surgeons should make a choice based on their own specific conditions and the patient's specific situation.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"476-481"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991877/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[2024 American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guideline: An interpretation of the diagnosis and management of acute isolated meniscal injury]. [2024年美国骨科学会(AAOS)临床实践指南:急性孤立性半月板损伤的诊断和治疗的解释]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601059
Qianjiang Xiong, Yunan Hu, Lei Fan, Jian Li, Weili Fu

Acute isolated meniscal injury is a common sports-related knee injury in clinical practice. In June 2024, the American Academy of Orthopaedic Surgeons (AAOS) released the latest Clinical Practice Guideline for the Management of Acute Isolated Meniscal Pathology. Based on rigorous evidence-based methodology, the guideline provides systematic recommendations regarding physical examination, imaging evaluation, and both non-operative and operative management strategies, classifying these recommendations according to the strength of evidence. This article aims to interpret the key points in the diagnosis and management of acute isolated meniscal injury, to inform clinical practice and guide future research.

急性孤立性半月板损伤是临床上常见的运动相关膝关节损伤。2024年6月,美国骨科学会(AAOS)发布了最新的急性孤立性半月板病理管理临床实践指南。基于严格的循证方法,该指南提供了关于体格检查、影像学评估以及非手术和手术管理策略的系统建议,并根据证据的强度对这些建议进行了分类。本文旨在阐述急性孤立性半月板损伤的诊断和处理要点,为临床实践提供参考,并指导今后的研究。
{"title":"[2024 American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guideline: An interpretation of the diagnosis and management of acute isolated meniscal injury].","authors":"Qianjiang Xiong, Yunan Hu, Lei Fan, Jian Li, Weili Fu","doi":"10.7507/1002-1892.202601059","DOIUrl":"10.7507/1002-1892.202601059","url":null,"abstract":"<p><p>Acute isolated meniscal injury is a common sports-related knee injury in clinical practice. In June 2024, the American Academy of Orthopaedic Surgeons (AAOS) released the latest Clinical Practice Guideline for the Management of Acute Isolated Meniscal Pathology. Based on rigorous evidence-based methodology, the guideline provides systematic recommendations regarding physical examination, imaging evaluation, and both non-operative and operative management strategies, classifying these recommendations according to the strength of evidence. This article aims to interpret the key points in the diagnosis and management of acute isolated meniscal injury, to inform clinical practice and guide future research.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"358-363"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991895/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research on tissue regeneration and engineered scaffold materials in prevention and treatment of lymphedema]. [组织再生及工程化支架材料防治淋巴水肿的研究]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202509027
Shaoxiang Yuan, Chengliang Deng

Objective: To summarize the research in tissue regeneration and engineered scaffold materials for the prevention and treatment of lymphedema.

Methods: The recent domestic and international literature about lymphangiogenesis-related factors, stem cells, and tissue engineered scaffold materials for the prevention and treatment of lymphedema was extensively reviewed and summarized, and the progress of tissue engineered scaffold materials in prevention and treatment of lymphedema was emphatically introduced.

Results: Lymphangiogenesis-related factors, stem cells, and tissue engineered scaffold materials utilize two main strategies to prevent and treat lymphedema: promoting lymphatic network regeneration in vivo and constructing functional lymphatic tissues for transplantation in vitro.

Conclusion: Tissue regeneration and engineered scaffold materials provide new approaches for the prevention and treatment of lymphedema. Although innovative developments have been made, most are still at the basic research stage, and clinical translation remains a challenge.

目的:综述组织再生及工程支架材料防治淋巴水肿的研究进展。方法:对近年来国内外有关淋巴管生成相关因子、干细胞、组织工程支架材料防治淋巴水肿的文献进行广泛的梳理和总结,重点介绍组织工程支架材料防治淋巴水肿的研究进展。结果:淋巴管生成相关因子、干细胞和组织工程支架材料采用两种主要策略来预防和治疗淋巴水肿:在体内促进淋巴网络再生和在体外构建用于移植的功能性淋巴组织。结论:组织再生和工程化支架材料为预防和治疗淋巴水肿提供了新的途径。虽然已经取得了创新进展,但大多数仍处于基础研究阶段,临床转化仍然是一个挑战。
{"title":"[Research on tissue regeneration and engineered scaffold materials in prevention and treatment of lymphedema].","authors":"Shaoxiang Yuan, Chengliang Deng","doi":"10.7507/1002-1892.202509027","DOIUrl":"10.7507/1002-1892.202509027","url":null,"abstract":"<p><strong>Objective: </strong>To summarize the research in tissue regeneration and engineered scaffold materials for the prevention and treatment of lymphedema.</p><p><strong>Methods: </strong>The recent domestic and international literature about lymphangiogenesis-related factors, stem cells, and tissue engineered scaffold materials for the prevention and treatment of lymphedema was extensively reviewed and summarized, and the progress of tissue engineered scaffold materials in prevention and treatment of lymphedema was emphatically introduced.</p><p><strong>Results: </strong>Lymphangiogenesis-related factors, stem cells, and tissue engineered scaffold materials utilize two main strategies to prevent and treat lymphedema: promoting lymphatic network regeneration <i>in vivo</i> and constructing functional lymphatic tissues for transplantation <i>in vitro</i>.</p><p><strong>Conclusion: </strong>Tissue regeneration and engineered scaffold materials provide new approaches for the prevention and treatment of lymphedema. Although innovative developments have been made, most are still at the basic research stage, and clinical translation remains a challenge.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"511-518"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of current status and trends of disease burden of neck pain in China from 1990 to 2023]. [1990 - 2023年中国颈部疼痛疾病负担现状及趋势分析]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601124
Zhiyi Lu, Jiahao Li, Jianhua Hu, Yu Zhao

Objective: Based on the data from the 2023 Global Burden of Disease (GBD) study, the changing trends of the disease burden of neck pain and its demographic characteristics in China from 1990 to 2023 was systematically evaluated, in order to provide evidence for the formulation of neck pain prevention and control strategies.

Methods: Data on the incidence, prevalence, years lived with disability (YLDs), and their age-standardized rates of neck pain in China were extracted from the GBD 2023 database. A descriptive analysis was conducted by stratifying data by gender and age. The Joinpoint regression model was used to analyze the temporal trends of age-standardized incidence, prevalence, and YLDs rates, and the average annual percentage change (AAPC) was calculated.

Results: From 1990 to 2023, the number of incident cases, prevalent cases, and YLDs of neck pain in China increased by 66.08%, 83.06%, and 80.49%, respectively, while the age-standardized rates showed relatively small fluctuations overall (rate of change<1.2%). The incidence, prevalence, and YLDs rates in females were higher than those in males, and the age-standardized YLDs rate in females showed a continuous upward trend (AAPC=0.067%, P<0.05). The disease burden of neck pain gradually increased with age, being most concentrated in middle-aged, elderly, and advanced-age populations. Joinpoint regression analysis revealed that the age-standardized incidence, prevalence, and YLDs rates exhibited multi-stage changes, with a common upward phase from 2005 to 2009 and a slight decline after 2021.

Conclusion: The increase in the absolute burden of neck pain in China is mainly driven by population aging. Priority should be given to focusing on female, middle-aged, and elderly populations, and early intervention should be strengthened to reduce long-term disability burden.

目的:基于2023年全球疾病负担(GBD)研究数据,系统评价1990 - 2023年中国颈痛疾病负担变化趋势及其人口学特征,为制定颈痛防治策略提供依据。方法:从GBD 2023数据库中提取中国颈部疼痛的发病率、患病率、残疾生活年限(YLDs)及其年龄标准化率的数据。对数据按性别和年龄分层进行描述性分析。采用Joinpoint回归模型分析年龄标准化发病率、患病率和YLDs率的时间趋势,计算年均百分比变化(AAPC)。结果:1990 - 2023年,中国颈部疼痛的发病例数、流行例数和YLDs分别增长了66.08%、83.06%和80.49%,而年龄标准化率的总体波动较小(变化率)。结论:中国颈部疼痛绝对负担的增加主要是由人口老龄化驱动的。重点关注女性、中老年人群,加强早期干预,减轻长期残疾负担。
{"title":"[Analysis of current status and trends of disease burden of neck pain in China from 1990 to 2023].","authors":"Zhiyi Lu, Jiahao Li, Jianhua Hu, Yu Zhao","doi":"10.7507/1002-1892.202601124","DOIUrl":"10.7507/1002-1892.202601124","url":null,"abstract":"<p><strong>Objective: </strong>Based on the data from the 2023 Global Burden of Disease (GBD) study, the changing trends of the disease burden of neck pain and its demographic characteristics in China from 1990 to 2023 was systematically evaluated, in order to provide evidence for the formulation of neck pain prevention and control strategies.</p><p><strong>Methods: </strong>Data on the incidence, prevalence, years lived with disability (YLDs), and their age-standardized rates of neck pain in China were extracted from the GBD 2023 database. A descriptive analysis was conducted by stratifying data by gender and age. The Joinpoint regression model was used to analyze the temporal trends of age-standardized incidence, prevalence, and YLDs rates, and the average annual percentage change (AAPC) was calculated.</p><p><strong>Results: </strong>From 1990 to 2023, the number of incident cases, prevalent cases, and YLDs of neck pain in China increased by 66.08%, 83.06%, and 80.49%, respectively, while the age-standardized rates showed relatively small fluctuations overall (rate of change<1.2%). The incidence, prevalence, and YLDs rates in females were higher than those in males, and the age-standardized YLDs rate in females showed a continuous upward trend (AAPC=0.067%, <i>P</i><0.05). The disease burden of neck pain gradually increased with age, being most concentrated in middle-aged, elderly, and advanced-age populations. Joinpoint regression analysis revealed that the age-standardized incidence, prevalence, and YLDs rates exhibited multi-stage changes, with a common upward phase from 2005 to 2009 and a slight decline after 2021.</p><p><strong>Conclusion: </strong>The increase in the absolute burden of neck pain in China is mainly driven by population aging. Priority should be given to focusing on female, middle-aged, and elderly populations, and early intervention should be strengthened to reduce long-term disability burden.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"405-413"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advances in application of hydrogels for treatment of osteonecrosis of the femoral head]. [水凝胶治疗股骨头坏死的研究进展]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202510062
Guangtao Han, Qianhao Li, Qin Wang, Pengde Kang

Objective: To summarize recent research advances of hydrogels for the treatment of osteonecrosis of the femoral head (ONFH).

Methods: The literature on hydrogels for treatment of ONFH at home and abroad in recent years was extensively reviewed, and the fundamental research and clinical application were summarized and analyzed.

Results: In the field of fundamental research, functionalized hydrogels (including thermosensitive, oxygen-controlled release, and ion-doped types) demonstrate significant advantages in achieving targeted delivery, controlled release, and microenvironment regulation. Particularly, the development of novel material systems, such as composite scaffold systems, gene-activated hydrogels, and engineered exosomes, has further enhanced treatment precision and biological efficacy. In terms of clinical application, the materials like recombinant human fibroblast growth factor 2 (rhFGF-2) gelatin hydrogels have been validated in multiple trials, showing promising joint preservation rates and bone regeneration capabilities. This opens a promising new clinical pathway for hip-preserving treatment of ONFH. Among these, hydrogel-based multilevel composite scaffolds represent the most promising materials for clinical translation.

Conclusion: Hydrogel systems, by synergistically regulating osteogenesis, angiogenesis, and immunomodulation, and leveraging the unique advantages of functionalized materials in precise drug control and microenvironment regulation, have evolved into advanced platforms for the comprehensive treatment of ONFH. Among them, rhFGF-2 gelatin hydrogels, with their remarkable clinical efficacy, offer a new strategy of significant translational value for hip-preserving therapy.

目的:总结水凝胶治疗股骨头坏死(ONFH)的研究进展。方法:广泛查阅近年来国内外关于水凝胶治疗ONFH的文献,对其基础研究和临床应用进行总结分析。结果:在基础研究领域,功能化水凝胶(包括热敏型、氧控释型和离子掺杂型)在实现靶向递送、控释和微环境调节方面具有显著优势。特别是,新型材料系统的发展,如复合支架系统、基因活化水凝胶和工程外泌体,进一步提高了治疗精度和生物功效。在临床应用方面,重组人成纤维细胞生长因子2 (rhFGF-2)明胶水凝胶等材料已在多次试验中得到验证,显示出良好的关节保存率和骨再生能力。这为保髋治疗ONFH开辟了一条有希望的临床新途径。其中,水凝胶基多层复合支架是最有希望用于临床翻译的材料。结论:水凝胶系统通过协同调节骨生成、血管生成和免疫调节,并利用功能化材料在精确药物控制和微环境调节方面的独特优势,已发展成为ONFH综合治疗的先进平台。其中,rhFGF-2明胶水凝胶具有显著的临床疗效,为保髋治疗提供了一种具有重要转化价值的新策略。
{"title":"[Advances in application of hydrogels for treatment of osteonecrosis of the femoral head].","authors":"Guangtao Han, Qianhao Li, Qin Wang, Pengde Kang","doi":"10.7507/1002-1892.202510062","DOIUrl":"10.7507/1002-1892.202510062","url":null,"abstract":"<p><strong>Objective: </strong>To summarize recent research advances of hydrogels for the treatment of osteonecrosis of the femoral head (ONFH).</p><p><strong>Methods: </strong>The literature on hydrogels for treatment of ONFH at home and abroad in recent years was extensively reviewed, and the fundamental research and clinical application were summarized and analyzed.</p><p><strong>Results: </strong>In the field of fundamental research, functionalized hydrogels (including thermosensitive, oxygen-controlled release, and ion-doped types) demonstrate significant advantages in achieving targeted delivery, controlled release, and microenvironment regulation. Particularly, the development of novel material systems, such as composite scaffold systems, gene-activated hydrogels, and engineered exosomes, has further enhanced treatment precision and biological efficacy. In terms of clinical application, the materials like recombinant human fibroblast growth factor 2 (rhFGF-2) gelatin hydrogels have been validated in multiple trials, showing promising joint preservation rates and bone regeneration capabilities. This opens a promising new clinical pathway for hip-preserving treatment of ONFH. Among these, hydrogel-based multilevel composite scaffolds represent the most promising materials for clinical translation.</p><p><strong>Conclusion: </strong>Hydrogel systems, by synergistically regulating osteogenesis, angiogenesis, and immunomodulation, and leveraging the unique advantages of functionalized materials in precise drug control and microenvironment regulation, have evolved into advanced platforms for the comprehensive treatment of ONFH. Among them, rhFGF-2 gelatin hydrogels, with their remarkable clinical efficacy, offer a new strategy of significant translational value for hip-preserving therapy.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"487-492"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991890/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Disease burden trends of site-specific osteoarthritis in China from 1990 to 2023 and the attribution to high body mass index]. [1990 - 2023年中国部位特异性骨关节炎疾病负担趋势及高体重指数归因]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601051
Qianjiang Xiong, Lin Hu, Yunan Hu, Qingsong Liu, Jian Li, Chunxia Yang, Weili Fu

Objective: To analyze the current status and temporal trends of the disease burden of osteoarthritis (OA) in China from 1990 to 2023, stratified by anatomical sites (knee, hip, hand, and other), utilizing data from the 2023 Global Burden of Disease (GBD) study, and to explore the site-specific heterogeneity of disease burden attributed to high body mass index (BMI), providing a scientific basis for formulating precision prevention and control strategies.

Methods: Based on the GBD 2023 database, data on the incidence, prevalence, and years lived with disability (YLDs), as well as their corresponding age-standardized rates of OA in China from 1990 to 2023, were collected and stratified by gender, age, and anatomical site (knee, hip, hand, and other). A log-linear regression model was employed to calculate the estimated annual percentage change (EAPC) to analyze temporal trends. Additionally, the population attributable fraction (PAF) was used to quantify the contribution of high BMI to OA across different sites and to analyze the heterogeneity of this attribution.

Results: In 2023, the disease burden of OA in China increased. In terms of anatomical distribution, knee OA constituted the heaviest burden, with 115.0032 million prevalent cases, accounting for approximately 65.78% of the total. Attribution analysis showed that knee OA was slightly more affected by high BMI than hip OA, and the PAF increased significantly over time. In 2023, the PAFs for knee and hip OA in females (29.49% and 28.57%, respectively) were substantially higher than those in 1990 (19.10% and 18.38%). A similar upward trend was observed in males (26.65% and 25.92% in 2023). Regarding attribution differences, female PAF levels were consistently higher than those of males across all years and sites. Hand OA exhibited the fastest growth rate, with the EAPC of its age-standardized YLDs rate reaching 1.64%, far exceeding that of knee OA (0.43%). Demographically, all burden indicators were higher in females than in males. Hand OA demonstrated an intergenerational cumulative effect. The difference in YLDs rates between 2023 and 1990 widened with age, reaching 123.29 per 100 000 in the >95 years old group, highlighting the severe challenges posed by population aging.

Conclusion: From 1990 to 2023, the disease burden of OA in China continued to rise. Knee OA remains the heaviest burden category and is significantly driven by high BMI, whereas hand OA shows the fastest growth trend. Prevention and control strategies should focus on weight management for knee and hip OA, while prioritizing the prevention and care of hand OA in the elderly population.

目的:利用2023年全球疾病负担(GBD)研究数据,分析1990 - 2023年中国骨关节炎(OA)疾病负担的现状和时间趋势,按解剖部位(膝关节、髋关节、手部等)分层,探讨高体重指数(BMI)疾病负担的部位特异性异质性,为制定精准防控策略提供科学依据。方法:基于GBD 2023数据库,收集1990年至2023年中国OA发病率、患病率、残疾生活年限(YLDs)及其相应的年龄标准化率数据,并按性别、年龄和解剖部位(膝关节、髋关节、手部等)进行分层。采用对数线性回归模型计算估算的年变化百分比(EAPC),分析其时间趋势。此外,使用人口归因分数(PAF)来量化不同地点高BMI对OA的贡献,并分析这种归因的异质性。结果:2023年中国OA疾病负担增加。从解剖分布上看,膝关节OA负担最重,共115,0032万例,约占总病例的65.78%。归因分析显示,高BMI对膝关节OA的影响略大于髋部OA,并且随着时间的推移,PAF显著增加。2023年,女性膝关节和髋部OA的paf(分别为29.49%和28.57%)明显高于1990年(19.10%和18.38%)。男性也有类似的上升趋势(2023年分别为26.65%和25.92%)。在归因差异方面,在所有年份和地点,女性PAF水平始终高于男性。手部OA增长最快,其年龄标准化YLDs率EAPC达到1.64%,远高于膝关节OA(0.43%)。在人口统计学上,女性的所有负担指标都高于男性。手关节炎表现出代际累积效应。2023年与1990年的土地生长增长率差距随着年龄的增长而扩大,95岁至95岁年龄组的土地生长增长率达到123.29 / 10万,凸显了人口老龄化带来的严峻挑战。结论:1990 - 2023年,中国OA疾病负担持续上升。膝关节OA仍然是最重的负担类别,明显受高BMI驱动,而手部OA增长趋势最快。预防和控制策略应侧重于膝关节和髋部OA的体重管理,同时优先考虑老年人群手部OA的预防和护理。
{"title":"[Disease burden trends of site-specific osteoarthritis in China from 1990 to 2023 and the attribution to high body mass index].","authors":"Qianjiang Xiong, Lin Hu, Yunan Hu, Qingsong Liu, Jian Li, Chunxia Yang, Weili Fu","doi":"10.7507/1002-1892.202601051","DOIUrl":"10.7507/1002-1892.202601051","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the current status and temporal trends of the disease burden of osteoarthritis (OA) in China from 1990 to 2023, stratified by anatomical sites (knee, hip, hand, and other), utilizing data from the 2023 Global Burden of Disease (GBD) study, and to explore the site-specific heterogeneity of disease burden attributed to high body mass index (BMI), providing a scientific basis for formulating precision prevention and control strategies.</p><p><strong>Methods: </strong>Based on the GBD 2023 database, data on the incidence, prevalence, and years lived with disability (YLDs), as well as their corresponding age-standardized rates of OA in China from 1990 to 2023, were collected and stratified by gender, age, and anatomical site (knee, hip, hand, and other). A log-linear regression model was employed to calculate the estimated annual percentage change (EAPC) to analyze temporal trends. Additionally, the population attributable fraction (PAF) was used to quantify the contribution of high BMI to OA across different sites and to analyze the heterogeneity of this attribution.</p><p><strong>Results: </strong>In 2023, the disease burden of OA in China increased. In terms of anatomical distribution, knee OA constituted the heaviest burden, with 115.0032 million prevalent cases, accounting for approximately 65.78% of the total. Attribution analysis showed that knee OA was slightly more affected by high BMI than hip OA, and the PAF increased significantly over time. In 2023, the PAFs for knee and hip OA in females (29.49% and 28.57%, respectively) were substantially higher than those in 1990 (19.10% and 18.38%). A similar upward trend was observed in males (26.65% and 25.92% in 2023). Regarding attribution differences, female PAF levels were consistently higher than those of males across all years and sites. Hand OA exhibited the fastest growth rate, with the EAPC of its age-standardized YLDs rate reaching 1.64%, far exceeding that of knee OA (0.43%). Demographically, all burden indicators were higher in females than in males. Hand OA demonstrated an intergenerational cumulative effect. The difference in YLDs rates between 2023 and 1990 widened with age, reaching 123.29 per 100 000 in the >95 years old group, highlighting the severe challenges posed by population aging.</p><p><strong>Conclusion: </strong>From 1990 to 2023, the disease burden of OA in China continued to rise. Knee OA remains the heaviest burden category and is significantly driven by high BMI, whereas hand OA shows the fastest growth trend. Prevention and control strategies should focus on weight management for knee and hip OA, while prioritizing the prevention and care of hand OA in the elderly population.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"369-377"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Trends in burden of osteoporosis in China from 1990 to 2023 and analysis of epidemiological factors]. 1990 - 2023年中国骨质疏松症负担趋势及流行病学因素分析
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601066
Yunxiao Wu, Zepeng Lai, Huan Yan, Bangmin Zhou, Weizhong Chen, Ziqian Zeng

Objective: To analyze the trends in the burden of osteoporosis-related disease in China and worldwide from 1990 to 2023, and to further estimate the attributable burden of key determinants, so as to inform the formulation of prevention and control strategies for osteoporosis.

Methods: Based on the 2023 Global Burden of Disease (GBD) study database, the data on mortality, disability adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) attributable to low bone mineral density (LBMD) among individuals aged 40 years and older in China and globally from 1990 to 2023 were collected. Metrics focused primarily on age-standardized rates, and data were stratified by age group and gender. Joinpoint regression models were employed to estimate the annual percentage change (APC) and average annual percentage change (AAPC) to assess trends in the burden. An age-period-cohort analysis was conducted to characterize age, period, and birth cohort effects. Additionally, the Das Gupta decomposition method was applied to decompose the changes in the number of LBMD-attributable deaths in China from 1990 to 2023, quantifying the contributions of population growth, population aging, and changes in age-specific mortality rates.

Results: From 1990 to 2023, DALYs rates and YLLs rates attributable to LBMD showed an overall decreasing trend in both China and the world. DALYs rates declined from 311.54/100 000 to 268.55/100 000 in China and from 288.85/100 000 to 265.11/100 000 globally. In China, the YLDs rate increased from 170.42/100 000 to 197.91/100 000, whereas the global YLDs rate remained relatively stable. The burden of LBMD-related disease was consistently higher in women than in men. Falls were the leading cause of LBMD-attributable deaths and DALYs, followed by road injuries, while other types of injuries accounted for a relatively small proportion. Gupta decomposition showed that the number of LBMD-attributable deaths increased by 62.88% in men and 138.25% in women, primarily driven by population growth (contributing 108.33% in men and 138.98% in women) and population aging (contributing 42.26% in men and 70.59% in women), while changes in age-specific mortality rates offset the increase by 87.72% in men and 71.32% in women.

Conclusion: From 1990 to 2023, the mortality burden attributable to LBMD in China has decreased overall, but the disability burden has continued to rise, suggesting a shift in osteoporosis-related disease burden from lethality toward disability. Falls are the main attributable cause, and the burden is particularly high among older adults and women. Strengthening bone mineral density screening, fall prevention, and secondary fracture prevention and management is essential to reduce the long-term health losses associated with osteoporosis.

目的:分析1990 - 2023年中国及世界范围内骨质疏松相关疾病负担的变化趋势,进一步估算关键决定因素的归因负担,为骨质疏松防治策略的制定提供依据。方法:基于2023年全球疾病负担(GBD)研究数据库,收集1990 - 2023年中国和全球40岁及以上人群因低骨密度(LBMD)导致的死亡率、残疾调整生命年(DALYs)、残疾生活年(YLDs)和生命损失年(YLLs)数据。指标主要关注年龄标准化率,数据按年龄组和性别分层。采用连接点回归模型估算年百分比变化(APC)和平均年百分比变化(AAPC),以评估负担的趋势。进行了年龄-时期-队列分析,以表征年龄、时期和出生队列效应。此外,采用Das Gupta分解方法对1990年至2023年中国lbmd归因死亡人数的变化进行了分解,量化了人口增长、人口老龄化和年龄特异性死亡率变化的贡献。结果:从1990年到2023年,中国和世界LBMD的DALYs率和YLLs率总体呈下降趋势。DALYs比率在中国从311.54/10万下降到268.55/10万,在全球从288.85/10万下降到265.11/10万。在中国,YLDs率从170.42/10万上升到197.91/10万,而全球YLDs率保持相对稳定。lbmd相关疾病的负担在女性中始终高于男性。跌倒是导致lbmd导致的死亡和伤残调整生命年的主要原因,其次是道路伤害,而其他类型的伤害所占比例相对较小。Gupta分解显示,lbmd导致的死亡人数在男性中增加了62.88%,在女性中增加了138.25%,主要是由人口增长(在男性中占108.33%,在女性中占138.98%)和人口老龄化(在男性中占42.26%,在女性中占70.59%)驱动的,而年龄特异性死亡率的变化抵消了男性中占87.72%和女性中占71.32%的增长。结论:从1990年到2023年,中国由LBMD导致的死亡率负担总体下降,但残疾负担持续上升,表明骨质疏松相关疾病负担从致命性向致残性转变。跌倒是主要的可归因原因,老年人和妇女的负担特别高。加强骨密度筛查、预防跌倒和继发性骨折的预防和管理对于减少骨质疏松症相关的长期健康损失至关重要。
{"title":"[Trends in burden of osteoporosis in China from 1990 to 2023 and analysis of epidemiological factors].","authors":"Yunxiao Wu, Zepeng Lai, Huan Yan, Bangmin Zhou, Weizhong Chen, Ziqian Zeng","doi":"10.7507/1002-1892.202601066","DOIUrl":"10.7507/1002-1892.202601066","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the trends in the burden of osteoporosis-related disease in China and worldwide from 1990 to 2023, and to further estimate the attributable burden of key determinants, so as to inform the formulation of prevention and control strategies for osteoporosis.</p><p><strong>Methods: </strong>Based on the 2023 Global Burden of Disease (GBD) study database, the data on mortality, disability adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) attributable to low bone mineral density (LBMD) among individuals aged 40 years and older in China and globally from 1990 to 2023 were collected. Metrics focused primarily on age-standardized rates, and data were stratified by age group and gender. Joinpoint regression models were employed to estimate the annual percentage change (APC) and average annual percentage change (AAPC) to assess trends in the burden. An age-period-cohort analysis was conducted to characterize age, period, and birth cohort effects. Additionally, the Das Gupta decomposition method was applied to decompose the changes in the number of LBMD-attributable deaths in China from 1990 to 2023, quantifying the contributions of population growth, population aging, and changes in age-specific mortality rates.</p><p><strong>Results: </strong>From 1990 to 2023, DALYs rates and YLLs rates attributable to LBMD showed an overall decreasing trend in both China and the world. DALYs rates declined from 311.54/100 000 to 268.55/100 000 in China and from 288.85/100 000 to 265.11/100 000 globally. In China, the YLDs rate increased from 170.42/100 000 to 197.91/100 000, whereas the global YLDs rate remained relatively stable. The burden of LBMD-related disease was consistently higher in women than in men. Falls were the leading cause of LBMD-attributable deaths and DALYs, followed by road injuries, while other types of injuries accounted for a relatively small proportion. Gupta decomposition showed that the number of LBMD-attributable deaths increased by 62.88% in men and 138.25% in women, primarily driven by population growth (contributing 108.33% in men and 138.98% in women) and population aging (contributing 42.26% in men and 70.59% in women), while changes in age-specific mortality rates offset the increase by 87.72% in men and 71.32% in women.</p><p><strong>Conclusion: </strong>From 1990 to 2023, the mortality burden attributable to LBMD in China has decreased overall, but the disability burden has continued to rise, suggesting a shift in osteoporosis-related disease burden from lethality toward disability. Falls are the main attributable cause, and the burden is particularly high among older adults and women. Strengthening bone mineral density screening, fall prevention, and secondary fracture prevention and management is essential to reduce the long-term health losses associated with osteoporosis.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"378-386"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国修复重建外科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1